In focus · trending topic

Keith S. Kaye

1 stories · following the connections

Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™ (meropenem and vaborbactam) in Patients with cUTI

By Nasdaq OMXFeb 27, 2018, 9:05 PM UTC